Richard
This just posted on PRN. I have no idea of the extent to which quick approval for the hydrobrush has already been discounted in the current price, but its nice to see MDJT getting some publicity.
Friday May 2 10:10 AM EDT Medjet announces 510(k) filing for HydroBrush Keratome EDISON, N.J.--(BW HealthWire)--May 2, 1997--Medjet Inc. (NASD: MDJT common; MDJTW warrants), a leading developer of surgical cutting devices based on high-velocity water jets, today announced that the United States Food and Drug Administration is processing the company's Section 510(k) application for permission to market its HydroBrush(TM) Keratome. The intended use is the removal of the epithelium from the cornea over a defined circular area. Removing (debriding) the epithelium, or outer surface of the cornea, is the first step in excimer laser refractive surgery, known as photo-refractive keratectomy, or PRK. Removal of the epithelium is also required in treating various corneal problems associated with disease, infection, dystrophy and physical damage to the epithelium. The new technique is substantially quicker than currently used techniques. Based on animal studies, the company has shown that the new procedure leaves the corneal surface cleaner, less damaged and better defined than currently used techniques. In addition, the corneal surface heals significantly faster. Those are important advantages for PRK. The company cautioned that there can be no assurance that the ruling of substantial equivalence will be made (thereby allowing marketing in the U.S.) or that the ruling would be made on a timely basis. As part of the process of bringing the HydroBrush(TM) Keratome to market in the U.S., the company is currently engaged in discussions with four research institutions for clinical tests of the HydroBrush(TM) Keratome, to be performed solely for the purpose of establishing ease of use. The HydroBrush(TM) Keratome is a surgeon-controlled cutting tool that utilizes a hair-thin, high-speed waterjet beam activated by compressed gas. All statements regarding the anticipated or expected benefits of the HydroBrush(TM) Keratome and the timetable for testing the HydroBrush(TM) Keratome are merely projections and may not be realized. CONTACT: Medjet Inc. Eugene I. Gordon, 908/738-3990 or Lobsenz Stevens Inc. Mark Perlgut, 212/684-6300, ext. 309
______________________________________________________________________
Happy Trading! |